MedTrace Logo

Extracorporeal Membrane Oxygenation for Respiratory Failure Patients

NCT06231446 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-01-30

No results posted yet for this study

Summary

The present study is a multicentre cohort study. Respiratory failure patients treated with extracorporeal membrane oxygenation (ECMO) were enrolled. Clinical data before and during ECMO treatment were collected. Clinical data before and during ECMO treatment were collected. By this retrospective clinical data and prospective study, to observe the current status of respiratory failure patients treated with ECMO in China, analyze the clinical characteristics and prognosis of patients, and explore the clinical prevention and treatment strategies of major complications of ECMO.

Conditions

  • Respiratory Failure Patients Treated With ECMO

Interventions

OTHER

No intervention

This was an observational cohort study with no intervention for all enrolled patients.

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06231446 on ClinicalTrials.gov